Description:

RVI is a specific immunomodulator agent (IMA) with subvaccination levels of an inactivated rubeola virus that acts to modify the immune and inflammatory responses to alleviate Chronic Myofascial Inflammation (chronic muscle soreness) and its associated problems in the equine.

Information:

RVI administered subcutaneously, stimulates the same kind of healing afforded by extended rest. But instead of taking months to see results to see results, RVI works in just days. RVI acts on a target site in the immune system to restore the proper balance among all its components. T-lymphocytes, and especially suppressor T-cells, are the primary control cells of the immune response. They function to restrain the B-cells (the antibody producers) and other forms of T-cells from over-responding to insult and from mounting an immune responses to auto (self) antigens.

Benefits:

RVI WILL NOT BE EFFECTIVE.

Administration:

Inject 2 mL subcutaneously in neck of horses daily, regardless of weight or age, for six days or until desired clinical response is observed. This may be more than 6 days in some cases. After the initial treatment period, a maintenance 2 mL dose should be given 24 hour pre-performance (racing, showing, etc.) or on regular intervals from 2-4 weeks depending on the individual. CARE SHOULD BE EXERCISED TO ENSURE THAT THE INJECTION IS DELIVERED SUBCUTANEOUSLY IN THE NECK.

Packaging:

12 mL Vial – (6 doses)